PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
-2.7%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$2.09B
AUM Growth
+$2.09B
(-16%)
Cap. Flow
-$281M
Cap. Flow
% of AUM
-13.46%
Top 10 Holdings %
Top 10 Hldgs %
34.86%
Holding
87
New
5
Increased
22
Reduced
20
Closed
15
Top Buys
| 1 |
Lantheus
LNTH
|
$25.9M |
| 2 |
Veeva Systems
VEEV
|
$16.6M |
| 3 |
IMGN
Immunogen Inc
IMGN
|
$13.8M |
| 4 |
Day One Biopharmaceuticals
DAWN
|
$13.2M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$13.1M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$112M |
| 2 |
Penumbra
PEN
|
$40.5M |
| 3 |
Dynavax Technologies
DVAX
|
$34.9M |
| 4 |
Stryker
SYK
|
$33.6M |
| 5 |
Waters Corp
WAT
|
$25.2M |
Sector Composition
| 1 | Healthcare | 97.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Arcellx
ACLX
$3.88B
| $8.62M | 0.41% |
240,338
-15,494
| -6% | -$556K |
|
|
ADAP
52
Adaptimmune Therapeutics
ADAP
$14.6M
| $8.13M | 0.38% |
10,423,135
+2,065,893
| +25% | +$1.61M |
|
53
PMV Pharmaceuticals
PMVP
$82.1M
| $7.95M | 0.37% |
1,295,104
+1,066,694
| +467% | +$6.55M |
|
54
Erasca
ERAS
$403M
| $7.74M | 0.36% |
3,930,633
-866,827
| -18% | -$1.71M |
|
|
TSBX
55
DELISTED
Turnstone Biologics
TSBX
| $6.01M | 0.28% |
+1,524,710
| New | +$6.01M |
|
56
Sagimet Biosciences
SGMT
$246M
| $5.95M | 0.28% |
+676,453
| New | +$5.95M |
|
57
Viridian Therapeutics
VRDN
$1.61B
| $5.54M | 0.26% |
360,830
+67,690
| +23% | +$1.04M |
|
58
Werewolf Therapeutics
HOWL
$60.8M
| $5.47M | 0.26% |
2,558,282
+254,391
| +11% | +$544K |
|
|
INBX
59
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $5.3M | 0.25% |
288,617
+160,914
| +126% | +$2.95M |
|
60
Sana Biotechnology
SANA
$741M
| $4.81M | 0.23% |
1,244,139
+1,230,173
| +8,808% | +$4.76M |
|
|
61
Stryker
SYK
$148B
| $3.31M | 0.16% |
12,106
-122,916
| -91% | -$33.6M |
|
62
Xenon Pharmaceuticals
XENE
$3.06B
| $2.68M | 0.13% |
78,587
-21,560
| -22% | -$736K |
|
63
Celcuity
CELC
$2.29B
| $1.92M | 0.09% |
210,551
-47,162
| -18% | -$431K |
|
64
IO Biotech
IOBT
$112M
| $1.91M | 0.09% |
1,353,453
+740,740
| +121% | +$1.04M |
|
65
Oscar Health
OSCR
$4.44B
| $1.87M | 0.09% |
336,166
| – | – |
|
66
Editas Medicine
EDIT
$239M
| $642K | 0.03% |
82,281
-358,889
| -81% | -$2.8M |
|
|
CMPS
67
Compass Pathways
CMPS
$454M
| $391K | 0.02% |
52,871
-122,410
| -70% | -$906K |
|
68
Apellis Pharmaceuticals
APLS
$3.55B
| – | – |
-274,498
| Closed | -$25M |
|
69
Boston Scientific
BSX
$159B
| – | – |
-268,397
| Closed | -$14.5M |
|
|
70
Dynavax Technologies
DVAX
$1.19B
| – | – |
-2,704,917
| Closed | -$34.9M |
|
71
iShares China Large-Cap ETF
FXI
$6.64B
| – | – |
-398,720
| Closed | -$10.8M |
|
72
Iovance Biotherapeutics
IOVA
$814M
| – | – |
-946,305
| Closed | -$6.66M |
|
73
Invesco S&P 500 Equal Weight ETF
RSP
$73.4B
| – | – |
0
| – | – |
|
|
VERV
74
DELISTED
Verve Therapeutics
VERV
| – | – |
-186,087
| Closed | -$3.49M |
|
|
75
Waters Corp
WAT
$17.5B
| – | – |
-94,624
| Closed | -$25.2M |
|